Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5401
FT Vest US Equity Buffer ETF September
FSEP
$1.42B
| $526K | ﹤0.01% |
9,550
+1,200
| +14% | +$64.6K |
2024 Q3
7 quarters
|
|
5402
Eaton Vance Senior Income Trust
EVF
$87.2M
| $525K | ﹤0.01% |
105,332
-6,364
| -6% | -$31.7K |
2013 Q2
52 quarters
|
|
5403
Ponce Financial Group
PDLB
$487M
| $521K | ﹤0.01% |
26,116
-7,646
| -23% | -$140K |
2018 Q2
32 quarters
|
|
5404
Fidelity US Multifactor ETF
FLRG
$294M
| $521K | ﹤0.01% |
12,691
+12,690
| +1,269,000% | +$507K |
2026 Q1
1 quarter
|
|
5405
Lyell Immunopharma
LYEL
$205M
| $521K | ﹤0.01% |
37,050
-19,101
| -34% | -$346K |
2021 Q2
20 quarters
|
|
5406
EPR Properties 5.75% Series C Preferred Shares
EPR.PRC
$133M
| $520K | ﹤0.01% |
20,290
-2,663
| -12% | -$67.6K |
2021 Q4
18 quarters
|
|
5407
First Capital
FCAP
$208M
| $520K | ﹤0.01% |
8,042
-604
| -7% | -$34.8K |
2013 Q4
50 quarters
|
|
5408
Tucows
TCX
$115M
| $520K | ﹤0.01% |
38,572
+14,967
| +63% | +$227K |
2014 Q1
49 quarters
|
|
5409
National Bankshares
NKSH
$275M
| $519K | ﹤0.01% |
14,277
-7,432
| -34% | -$268K |
2013 Q4
50 quarters
|
|
5410
Acme United Corp
ACU
$236M
| $516K | ﹤0.01% |
10,820
+4,334
| +67% | +$190K |
2013 Q4
50 quarters
|
|
5411
Union Bankshares
UNB
$113M
| $515K | ﹤0.01% |
21,236
+1,434
| +7% | +$34.5K |
2013 Q4
50 quarters
|
|
5412
Grandstand Ltd
GRSD
$49.5M
| $514K | ﹤0.01% |
270,707
-371,392
| -58% | -$1.16M |
2021 Q3
19 quarters
|
|
5413
Clipper Realty
CLPR
$51.1M
| $514K | ﹤0.01% |
189,066
-442
| -0.2% | -$1.39K |
2017 Q1
37 quarters
|
|
5414
Unicycive Therapeutics
UNCY
$101M
| $514K | ﹤0.01% |
109,645
-78,537
| -42% | -$579K |
2024 Q4
6 quarters
|
|
5415
Calvert US Mid-Cap Core Responsible Index ETF
CVMC
$119M
| $514K | ﹤0.01% |
6,754
-173,679
| -96% | -$12.3M |
2023 Q1
13 quarters
|
|
5416
ChipMOS TECHNOLOGIES
IMOS
$2.22B
| $512K | ﹤0.01% |
7,970
+6,617
| +489% | +$350K |
2013 Q2
52 quarters
|
|
5417
First Trust Exchange-Traded Fund VI First Trust BuyWrite Income ETF
FTHI
$2.56B
| $510K | ﹤0.01% |
21,372
-4,677
| -18% | -$111K |
2016 Q4
38 quarters
|
|
5418
Smith Douglas Homes
SDHC
$85.2M
| $510K | ﹤0.01% |
32,795
+22,487
| +218% | +$299K |
2024 Q1
9 quarters
|
|
5419
Oportun Financial
OPRT
$418M
| $509K | ﹤0.01% |
89,140
-36,694
| -29% | -$197K |
2019 Q4
26 quarters
|
|
5420
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
$315M
| $508K | ﹤0.01% |
20,709
-599
| -3% | -$15K |
2021 Q4
18 quarters
|
|
5421
Pro-Dex
PDEX
$194M
| $507K | ﹤0.01% |
8,664
-5,549
| -39% | -$322K |
2019 Q1
29 quarters
|
|
5422
abrdn Emerging Markets Dividend Active ETF
AGEM
$349M
| $506K | ﹤0.01% |
10,237
-591
| -5% | -$27.8K |
2025 Q1
5 quarters
|
|
5423
Anavex Life Sciences
AVXL
$139M
| $505K | ﹤0.01% |
194,963
-162,784
| -46% | -$482K |
2015 Q4
42 quarters
|
|
5424
Global X MSCI Norway ETF
NORW
$93.1M
| $504K | ﹤0.01% |
15,796
-7,997
| -34% | -$300K |
2020 Q3
23 quarters
|
|
5425
Lands' End
LE
$304M
| $502K | ﹤0.01% |
47,934
-12,419
| -21% | -$143K |
2014 Q2
48 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.